Sucrose & SUCROSE Excipient Use in Transmucosal Dosage Forms

Sucrose

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

10 Listed Products, 1 Pfanstiehl, 1 Actylis, 1 DKSH, 1 Gangwal Chemicals, 6 Seppic

REGULATORY FILINGS

6 Suppliers, 6 USDMF, 4 NDC API

SOLUTIONS BY APPLICATIONS

9 Coating Systems & Additives, 3 Taste Masking, 2 Thickeners and Stabilizers, 2 Coloring Agents

ANALYTICAL SOLUTION(s)

3 Other Ref. Standards

3 Other Ref. Standards

FINISHED FORMULATIONS

628 ORAL, 145 TABLET, 81 CAPSULE, EXTENDED RELEASE, 67 SOLUTION, 66 FOR SUSPENSION, 54 CAPSULE, 52 CAPSULE, DELAYED REL PELLETS, 50 SYRUP, 41 SUSPENSION, 18 TABLET, EXTENDED RELEASE, 13 CAPSULE, DELAYED RELEASE, 13 INJECTABLE, 11 INJECTION, 11 POWDER, 9 FOR SOLUTION, 9 SUSPENSION, EXTENDED RELEASE, 8 INTRAVENOUS, 8 TABLET, CHEWABLE, 7 ORAL-28, 6 ORAL-21, 6 TABLET, DELAYED RELEASE, 5 TABLET, ORALLY DISINTEGRATING, 4 GRANULE, 4 VIAL, 3 ELIXIR, 3 SUBCUTANEOUS, 2 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, 2 CONCENTRATE, 2 FOR SUSPENSION, EXTENDED RELEASE, 2 INJECTABLE, LIPOSOMAL, 2 SUSPENSION/DROPS, 2 TRANSMUCOSAL, 2 TROCHE/LOZENGE, 1 EMULSION, 1 INTRAVENOUS, SUBCUTANEOUS, 1 IV (INFUSION), 1 NASAL, 1 POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER, 1 SINGLE-USE, 1 SPRAY, METERED, 1 SUBCUTANEOUS LYOPHILIZED POWER, 1 SYRINGE